Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Language
Publication year range
1.
Transfus Apher Sci ; 47(1): 85-9, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22609019

ABSTRACT

Iron deficiency (ID) is a global health problem. We aimed to determine the prevalence of ID at the first year of life in infants who were hospitalized in our neonatal intensive care unit (NICU) and investigate the effects of various factors on iron status. One year follow-up data of 219 infants who were discharged from NICU was retrospectively evaluated. ID anemia and ID without anemia were detected in fifteen infants (6.8%) and five (2.3%) infants, respectively. We concluded that, due to prophylactic iron treatment and close follow-up, hospitalization in neonatal period did not have any adverse effect on iron status at first year of life.


Subject(s)
Anemia, Iron-Deficiency/epidemiology , Hospitalization , Iron Deficiencies , Anemia, Iron-Deficiency/blood , Anemia, Iron-Deficiency/prevention & control , Female , Follow-Up Studies , Humans , Infant , Male , Prevalence
2.
Turk J Pediatr ; 53(3): 337-41, 2011.
Article in English | MEDLINE | ID: mdl-21980820

ABSTRACT

Congenital cystic adenomatoid malformation (CCAM) is a rare bronchopulmonary malformation characterized by loss of the normal pulmonary tissue. CCAM may be frequently associated with cardiac and renal anomalies. Rarely, CCAM may be seen with chromosome abnormalities. This is the first reported neonatal case of prenatally detected CCAM and postnatally diagnosed trisomy 13.


Subject(s)
Abnormalities, Multiple/genetics , Chromosomes, Human, Pair 13 , Cystic Adenomatoid Malformation of Lung, Congenital/diagnostic imaging , Trisomy , Ultrasonography, Prenatal , Abnormalities, Multiple/pathology , Cystic Adenomatoid Malformation of Lung, Congenital/complications , Female , Humans , Infant, Newborn
3.
Genet Couns ; 22(2): 161-4, 2011.
Article in English | MEDLINE | ID: mdl-21848008

ABSTRACT

A neonatal case of left ventricular non-compaction associated with trisomy 18: Left ventricular noncompaction (LVNC) is a rare congenital cardiomyopathy and exact etiology is still unknown. Trisomy 18 is the second most common autosomal trisomy in live-born infants. LVNC has been described in association with other dysmorphic features, association with trisomy 18 has not been reported previously in a neonate. LVNC broadens the cardiac anomalies associated with trisomy 18.


Subject(s)
Chromosomes, Human, Pair 18 , Heart Ventricles/abnormalities , Isolated Noncompaction of the Ventricular Myocardium/genetics , Trisomy , Female , Heart Ventricles/diagnostic imaging , Humans , Infant, Newborn , Isolated Noncompaction of the Ventricular Myocardium/diagnostic imaging , Male , Pregnancy , Ultrasonography , Young Adult
4.
Turk J Pediatr ; 53(1): 19-26, 2011.
Article in English | MEDLINE | ID: mdl-21534335

ABSTRACT

The purpose of this article is to report our experience with intravenous voriconazole therapy in the treatment of persistent Candida septicemia in very low birth weight (VLBW) neonates. Candidiasis was defined if an infant had a positive blood culture. Ten VLBW newborns developed Candida sepsis, and candidemia persisted in 6 of them despite 3 to 21 days of antifungal therapy with amphotericin B, either conventional or liposomal, and fluconazole. After the addition of voriconazole, clearance of Candida was achieved within 3-7 days of treatment. Antifungal therapy combination with liposomal amphotericin B and voriconazole was continued for at least two weeks after two negative cultures 48 hours apart. We conclude that considering the hazardous effects of Candida infections in preterm newborns, voriconazole can be added to the treatment of fungal sepsis in newborns who still have persistent candidemia despite conventional antifungal management. More clinical information is needed before voriconazole can be used as a first-line drug in antifungal therapy in newborns.


Subject(s)
Antifungal Agents/therapeutic use , Candidemia/drug therapy , Infant, Premature, Diseases/drug therapy , Infant, Very Low Birth Weight , Pyrimidines/therapeutic use , Triazoles/therapeutic use , Amphotericin B/therapeutic use , Drug Therapy, Combination , Humans , Infant, Newborn , Infant, Premature , Voriconazole
5.
Eur J Pediatr Surg ; 20(5): 339-40, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20625976

ABSTRACT

INTRODUCTION: The aim of this study was to determine the normal position of the umbilicus so as to offer a guide to improve cosmetic results after the repair of congenital abdominal wall defects. MATERIALS AND METHODS: The position of the umbilical center was determined in 187 neonates with respect to the xiphoid process, the center of the umbilicus and the pubis. The distance between the xiphoid process and the center of the umbilicus (XU), between the pubis and the center of the umbilicus (PU) and from the xiphoid process to the pubis (XP) were measured while the babies lay in a supine position. The PU:XU ratio was calculated based on these measurements. RESULTS: Mean XP was 11.93±1.40 cm, mean XU was 7.41±1.08 cm and mean PU was 4.52±0.70 (mean±SD). The PU:XU ratio was calculated as 0.61±0.12 (ratio±SD). CONCLUSION: We suggest that the PU:XU ratio should be 0.61 offering an ideal localization in umbilical reconstruction.


Subject(s)
Umbilicus/anatomy & histology , Anthropometry , Female , Humans , Infant, Newborn , Male , Pubic Bone/anatomy & histology , Xiphoid Bone/anatomy & histology
6.
Eur J Pediatr Surg ; 18(1): 56-8, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18302073

ABSTRACT

Enterocutaneous fistula (EF) in newborns and prematures is a well-recognized complication after necrotizing enterocolitis and other abdominal surgical procedures. Conservative management consists of bowel rest, antibiotics, wound care, and the administration of drugs that either reduce gastrointestinal motility or secretions. Octreotide decreases gastrointestinal secretions, inhibits or blocks the effects of gastrointestinal hormones, diminishes gut motility and thus reduces the flow through the fistula. We used octreotide and were able to report successful spontaneous closure of a fistula in our 2 neonatal patients, one a premature neonate with necrotizing enterocolitis (NEC) and the other with meconium peritonitis.


Subject(s)
Digestive System Surgical Procedures/adverse effects , Gastrointestinal Agents/therapeutic use , Intestinal Fistula/drug therapy , Intestinal Fistula/etiology , Octreotide/therapeutic use , Female , Humans , Infant, Newborn , Infant, Premature , Male
SELECTION OF CITATIONS
SEARCH DETAIL